Deep Brain Stimulation In Parkinson's Disease Market Worth $1.42 Billion By 2028: Grand View Research, Inc.

SAN FRANCISCO, Aug. 3, 2020 /PRNewswire/ -- The global deep brain stimulation in parkinson's disease market size is anticipated to reach USD 1.42 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.5% from 2020 to 2028. Surge in the incidence of Parkinson's Disease (PD) and growing awareness about the deep brain stimulation in PD are driving the market.

Rising prevalence of Parkinson's disease has raised the demand for deep brain stimulators as an alternative therapy. Deep brain stimulation has been proved to play an important role in providing therapeutic solutions for the symptoms of Parkinson's disease, which is expected to fuel the market growth during the forecast period.

Key suggestions from the report:

• The dual channel segment dominated the market with the share of 57.2% in 2019 owing to its increasing adoption by neurosurgeons as it is highly effective in reducing patient tremors
• On the basis of end use, hospitals dominated the market with a share of 52.1% in 2019 since deep brain stimulation procedures are the most complicated and critical surgeries that are performed in hospitals due to availability of high quality and durable equipment
• North America dominated the market with a revenue share of 52.3% in 2019 owing to prevalence of psychological disorders and presence of well-established healthcare facilities in the region.

Read 96 page research report with ToC on "Deep Brain Stimulation in Parkinson's Disease Market Size, Share & Trends Analysis Report By Product (Single Channel, Dual Channel), By End Use (Hospitals, ASCs), By Region, And Segment Forecasts, 2020 - 2028" at: https://www.grandviewresearch.com/industry-analysis/deep-brain-stimulation-parkinsons-disease-market 

Moreover, increasing demand for minimally invasive therapies due to improved patient outcomes is a high impact rendering driver for this market. This is due to high cost efficiency, minimal pain, safety, short duration of hospital stays, speedy recovery, and few cases of post-surgical problems. These key factors are anticipated to raise the demand for deep brain stimulators over the forecast period.

In addition, technological advancements by the key players for the improved postoperative outcomes and reduced adverse effects in the treatment of PD symptoms are anticipated to raise the demand for deep brain stimulation. For instance, in January 2020, Abbott's Infinity deep brain stimulation system has secured expanded indication approval from the FDA for the treatment of PD. This system will allow to target patients' specific area of the brain called internal globus pallidus (GPi), which is associated with Parkinson's disease symptoms.

Grand View Research has segmented the global DBS in Parkinson's disease market on the basis of product, end use, and region:

• DBS In Parkinson's Disease Product Outlook (Revenue, USD Million, 2016 - 2028)
• Single Channel Deep Brain Stimulator
• Dual Channel Deep Brain Stimulator
• DBS In Parkinson's Disease End-use Outlook (Revenue, USD Million, 2016 - 2028)
• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers (ASCs)
• Research Centers
• DBS In Parkinson's Disease Regional Outlook (Revenue, USD Million, 2016 - 2028)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• Latin America
• Mexico
• Brazil
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• List of Key Players of Deep Brain Stimulation In Parkinson's Disease Market
• Medtronic
• Boston Scientific Corporation
• Abbott

Find more research reports on Medical Devices Industry, by Grand View Research:

• COVID-19 Clinical Trials Market – Global COVID-19 clinical trials market size is valued at 5.0 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2021 to 2027.
• MRI-guided Neurosurgical Ablation Market – Global MRI-guided neurosurgical ablation market size was valued at USD 493.4 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2020 to 2027.
• Uterine Fibroid Treatment Device Market – Global uterine fibroid treatment device market size was valued at USD 4.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2020 to 2027.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg